F5, Inc. (LON:0IL6)

Inozyme Pharma Revenue

F5, Inc. had revenue of $731.12M USD in the quarter ending March 31, 2025, with 7.30% growth. This brings the company's revenue in the last twelve months to $2.94B, up 5.61% year-over-year. In the fiscal year ending September 30, 2024, F5, Inc. had annual revenue of $2.82B with 0.10% growth.

• Revenue (ttm): $2.94B
• Revenue Growth: +5.61%
• P/S Ratio: 5.90
• Revenue / Employee: $448.34K
• Employees: 6,557
• Market Cap: 13.43B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	2.82B	2.95M	0.10%
Sep 30, 2023	2.81B	117.32M	4.35%
Sep 30, 2022	2.70B	92.43M	3.55%
Sep 30, 2021	2.60B	252.59M	10.74%
Sep 30, 2020	2.35B	108.38M	4.83%